Would Screening for Lung Cancer Benefit 75- to 84-Year-Old Residents of the United States?

Background: The National Lung Screening Trial demonstrated that screening for lung cancer improved overall survival (OS) and reduced lung cancer mortality in the 55- to 74-year-old age group by increasing the proportion of cancers detected at an early stage. Because of the increasing life expectancy...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Varlotto, John M., DeCamp, Malcolm M., Flickinger, John C., Lake, Jessica, Recht, Abram, Belani, Chandra P., Reed, Michael F., Toth, Jennifer W., Mackley, Heath B., Sciamanna, Christopher N., Lipton, Alan, Ali, Suhail M., Mahraj, Richkesvar P. M., Gilbert, Christopher R., Yao, Nengliang
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2014
Teme:
Oncology
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3945517/
https://ncbi.nlm.nih.gov/pubmed/24639950
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2014.00037
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki